Locations:

Cancer

February 22, 2021/Cancer/Radiation Oncology

IMRT for Diffuse Cutaneous Breast Cancer Metastases

Minimizing patient discomfort, improving quality of life

February 16, 2021/Basic & Translational Science/Research

Identifying Actionable Cancer Mutations

Researchers develop a personalized genomic medicine platform to identify clinically actionable mutations

February 8, 2021/Cancer/Patient Support

New NCCN Guidelines Focus on Key Aspects of Survivorship

Patient resources promote healthy living, management of late and long-term side effects

650×450-Selpercatinib-in-Pediatric-Patients-with-RET-Altered-Tumors

February 4, 2021/Cancer

Durable Tumor Response and High Tolerability in Pediatric Patients With RET-Altered Tumors Taking Selpercatinib

Case reports of 2 single-patient protocols

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 27, 2021/Cancer

Integrating Medical Genetics Into the Care of Pediatric Oncology Patients

5 scenarios in which you should consider cancer predisposition

January 25, 2021/Cancer/News & Insight

The Cancer Center and Cleveland Clinic’s Centennial

Reflecting on our progress and potential

January 25, 2021/Cancer

Case Study: Total Neoadjuvant Treatment for Anal Adenocarcinoma Involving the Anal Sphincter

Avoiding abdominoperineal resection

January 21, 2021/Cancer/News & Insight

Managing CAR T-Cell Therapy Across Cancer Center Programs

Researching and operationalizing a new therapy

January 20, 2021/Basic & Translational Science

Selective Targeting May Have Therapeutic Potential in TET2-Mutant Neoplasia

TETi76 eliminates TET2-mutant and TET-deficient cancer cells

January 19, 2021/Cancer/News & Insight

COVID-19 mRNA Vaccines: What Does This Mean for Cancer?

Insights from the Director of the Center for Immunotherapy and Precision Immuno-Oncology

BackPage 46 of 87Next